File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Tumor targeting of functionalized quantum dot liposome hybrids by intravenous administration

TitleTumor targeting of functionalized quantum dot liposome hybrids by intravenous administration
Authors
KeywordsBiodistribution
Hybrid
ICP-MS
Liposomes
Pharmacokinetics
Quantum dots
Tumor targeting
Issue Date2009
Citation
Molecular Pharmaceutics, 2009, v. 6, n. 2, p. 520-530 How to Cite?
AbstractA strategy to target functionalized quantum dot-liposome (f-QD-L) hybrid vesicles in the solid tumor tissue of tumor-bearing mice is explored. Functionalized polyethylene glycol (PEG)- lipid coated QD (f-QD) were encapsulated into the aqueous core of 100 nm cationic (DOPC:Chol: DOTAP); sterically stabilized, fluid-phase (DOPC:Chol:DSPE-PEG2000); and sterically stabilized, gel- phase (DSPC:Chol:DSPE-PEG2000) liposome vesicles. Double tracking of f-QD-L in blood was performed at different time points after intravenous administration in B16F10 melanoma tumor- bearing C57BL6 mice. Cholesteryl [-1-14C] oleate lipids probed the vesicle membrane were followed by liquid scintillation counting while QD were determined independently by elemental (Cd2+) analysis using inductively coupled plasma mass spectrometry (ICP-MS). Rapid blood clearance was observed following intravenous administration of the cationic hybrid vesicles, while incorporation of PEG at the surface of zwitterionic vesicles dramatically prolonged their blood circulation half-life after systemic administration. The "rigid" PEGylated f-QD-L (DSPC:Chol:DSPE-PEG2000) hybrid vesicles led to rapid tumor accumulation of peak values (approximately 5% of injected dose per gram tissue) of QD compared to long-circulating f-QD that accumulated in the tumor tissue at longer time points. More interestingly, this hybrid vesicle tumor retention persisted for at least 24 h. For almost all types of systems, a preferential cadmium uptake by liver and spleen was obtained. Overall, f-QD-L hybrid vesicles offer great potential for tumor imaging applications due to their rapid accumulation and prolonged retention within the tumor. Furthermore, f-QD-L offer many opportunities for the development of combinatory therapeutic and imaging (theranostic) modalities by incorporating both drug molecules and QD within the different compartments of a single vesicle. © 2009 American Chemical Society.
Persistent Identifierhttp://hdl.handle.net/10722/348916
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 0.940

 

DC FieldValueLanguage
dc.contributor.authorAl-Jamal, Waf A.T.-
dc.contributor.authorAl-Jamal, Khuloud T.-
dc.contributor.authorTian, Bowen-
dc.contributor.authorCakebread, Andrew-
dc.contributor.authorHalket, John M.-
dc.contributor.authorKostarelos, Kostas-
dc.date.accessioned2024-10-17T06:54:55Z-
dc.date.available2024-10-17T06:54:55Z-
dc.date.issued2009-
dc.identifier.citationMolecular Pharmaceutics, 2009, v. 6, n. 2, p. 520-530-
dc.identifier.issn1543-8384-
dc.identifier.urihttp://hdl.handle.net/10722/348916-
dc.description.abstractA strategy to target functionalized quantum dot-liposome (f-QD-L) hybrid vesicles in the solid tumor tissue of tumor-bearing mice is explored. Functionalized polyethylene glycol (PEG)- lipid coated QD (f-QD) were encapsulated into the aqueous core of 100 nm cationic (DOPC:Chol: DOTAP); sterically stabilized, fluid-phase (DOPC:Chol:DSPE-PEG2000); and sterically stabilized, gel- phase (DSPC:Chol:DSPE-PEG2000) liposome vesicles. Double tracking of f-QD-L in blood was performed at different time points after intravenous administration in B16F10 melanoma tumor- bearing C57BL6 mice. Cholesteryl [-1-14C] oleate lipids probed the vesicle membrane were followed by liquid scintillation counting while QD were determined independently by elemental (Cd2+) analysis using inductively coupled plasma mass spectrometry (ICP-MS). Rapid blood clearance was observed following intravenous administration of the cationic hybrid vesicles, while incorporation of PEG at the surface of zwitterionic vesicles dramatically prolonged their blood circulation half-life after systemic administration. The "rigid" PEGylated f-QD-L (DSPC:Chol:DSPE-PEG2000) hybrid vesicles led to rapid tumor accumulation of peak values (approximately 5% of injected dose per gram tissue) of QD compared to long-circulating f-QD that accumulated in the tumor tissue at longer time points. More interestingly, this hybrid vesicle tumor retention persisted for at least 24 h. For almost all types of systems, a preferential cadmium uptake by liver and spleen was obtained. Overall, f-QD-L hybrid vesicles offer great potential for tumor imaging applications due to their rapid accumulation and prolonged retention within the tumor. Furthermore, f-QD-L offer many opportunities for the development of combinatory therapeutic and imaging (theranostic) modalities by incorporating both drug molecules and QD within the different compartments of a single vesicle. © 2009 American Chemical Society.-
dc.languageeng-
dc.relation.ispartofMolecular Pharmaceutics-
dc.subjectBiodistribution-
dc.subjectHybrid-
dc.subjectICP-MS-
dc.subjectLiposomes-
dc.subjectPharmacokinetics-
dc.subjectQuantum dots-
dc.subjectTumor targeting-
dc.titleTumor targeting of functionalized quantum dot liposome hybrids by intravenous administration-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1021/mp800187d-
dc.identifier.pmid19718803-
dc.identifier.scopuseid_2-s2.0-64649104312-
dc.identifier.volume6-
dc.identifier.issue2-
dc.identifier.spage520-
dc.identifier.epage530-
dc.identifier.eissn1543-8392-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats